DrugDashboards

Metronidazole

Metronidazole · METRONIDAZOLE 500 mg/100mL · Injection, Solution · Intravenous · WG Critical Care, LLC

NDC 44567-0750-24 · 24 POUCH in 1 CARTON / 1 BAG in 1 POUCH / 100 mL in 1 BAG · ANDA · View full market →

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now — FDA lists the reason as “other”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 25021-0131-82) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ
$0.0256per unit
middle half $0.0200–$0.0284 · 5,496 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.0256
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
100%of plans cover it
tier 3 · prior auth 8% · step therapy 0% · qty limit 0%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$2.28
Reported to Texas DSHS · 2026 annual filing · WG Critical Care

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$9
11 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $24.73 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA206191
TE code
AP
Approval date
Feb 25, 2019
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Flagyl I.v. Rtu In Plastic Container, Injection, 500 mg/100 mL (NDC 0338-1055-48)Jan 13, 2022
    month 56 — 3× the typical 20-month injectable shortage · model puts 33% odds it resolves within 6 months
  • In shortage now — Metronidazole in Flexible Container, Injection, 500 mg/100 mL (NDC 0409-0152-24)Jan 13, 2022
    Other
    month 56 — 3× the typical 20-month injectable shortage · model puts 33% odds it resolves within 6 months
  • In shortage now — Metronidazole In Plastic Container, Injection, 500 mg/100 mL (NDC 47335-993-01)Jan 13, 2022
    Discontinuation of the manufacture of the drug
    month 56 — 3× the typical 20-month injectable shortage · model puts 33% odds it resolves within 6 months
  • In shortage now — Metronidazole, Injection, 500 mg/100 mL (NDC 25021-131-82)Jan 13, 2022
    Other
    month 56 — 3× the typical 20-month injectable shortage · model puts 33% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Metronidazole (Injection, Solution)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationMETRONIDAZOLE 500 mg/100mLJul 15, 2026Sep 3, 2026
Amneal Pharmaceuticals Private LimitedMETRONIDAZOLE 500 mg/100mLJul 15, 2026Sep 2, 2026
Civica, Inc.METRONIDAZOLE 500 mg/100mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedMETRONIDAZOLE 500 mg/100mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.METRONIDAZOLE 500 mg/100mLJul 15, 2026Sep 2, 2026
Hospira, Inc.METRONIDAZOLE 5 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsMETRONIDAZOLE 500 mg/100mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.METRONIDAZOLE 500 mg/100mLJul 15, 2026Sep 2, 2026
WG Critical Care, LLCMETRONIDAZOLE 500 mg/100mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Metronidazole — NDC 44567-0750-24," retrieved September 3, 2026, https://drugdashboards.com/drug/44567075024.

Free to cite with attribution — see how the data is put together.